For example, use of a GLP-1 cut a patient's odds of kidney failure by 16% and a worsening of their kidney function by 22%, Budve and team reported
References [1] National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050 PubMed pubmed.ncbi.nlm.nih.gov [2] Worldwide trends in childhood overweight and obesity over the last 20 years PubMed pubmed.ncbi.nlm.nih.gov [3] National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 19902021, and forecasts up to 2050 ScienceDirect [4] Pediatric obesity
60 Additionally, there were no statistically significant differences in glycemic control between the two medications, and neither demonstrated significant benefits for liver fibrosis
Zhao J, Ouyang Y, Wang H, Lai H, Hu S, Tang L, et al